Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Depression

Free Subscription Articles published in JAMA Retrieve available abstracts of 59 articles: HTML format

Single Articles

April 2024
1. NITZAN I, Philips R, White RD
   Screening Recommendations and Treatments for Postpartum Depression.
   JAMA. 2024;331:1153-1154.
   PubMed    
   
   
   
2. MOORE SIMAS TA, Whelan A, Byatt N
   Screening Recommendations and Treatments for Postpartum Depression-Reply.
   JAMA. 2024;331:1154.
   PubMed    
   
   
   March 2024
3. VOELKER R
   What Is Perinatal Depression?
   JAMA. 2024 Mar 14. doi: 10.1001/jama.2024.0434.
   PubMed    
   
   
   February 2024
4. HARRIS E
   Meta-Analysis: Exercise as Effective as Therapy for Treating Depression.
   JAMA. 2024 Feb 28. doi: 10.1001/jama.2024.1121.
   PubMed    
   
   
   January 2024
5. HARRIS E
   Machine Learning Algorithms Failed to Find Depression Biomarker.
   JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28339.
   PubMed    
   
   
   
6. HARRIS E
   Perinatal Depression Tied to Higher Long-Term Risk of Death.
   JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28341.
   PubMed    
   
   
   
7. THORNBURG B, Kennedy-Hendricks A, Rosen JD, Eisenberg MD, et al
   Anxiety and Depression Symptoms After the Dobbs Abortion Decision.
   JAMA. 2024;331:294-301.
   PubMed     Abstract available
   
   
   November 2023
8. MOORE SIMAS TA, Whelan A, Byatt N
   Postpartum Depression-New Screening Recommendations and Treatments.
   JAMA. 2023 Nov 27. doi: 10.1001/jama.2023.21311.
   PubMed    
   
   
   October 2023
9. HARRIS E
   LSD Use Increasing More Among People With Depression.
   JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.20630.
   PubMed    
   
   
   
10. HARRIS E
    Esketamine More Effective Than Quetiapine for Hard-to-Treat Depression.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19797.
    PubMed    
    
    
    September 2023
11. AL-KAISEY AM, Parameswaran R, Bryant C, Anderson RD, et al
    Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A Randomized Clinical Trial.
    JAMA. 2023;330:925-933.
    PubMed     Abstract available
    
    
    
12. RAISON CL, Sanacora G, Woolley J, Heinzerling K, et al
    Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
    JAMA. 2023;330:843-853.
    PubMed     Abstract available
    
    
    August 2023
13. RUBIN R
    A Fast-Acting Pill Received Approval for Postpartum Depression-Is It a Game Changer?
    JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.16499.
    PubMed    
    
    
    July 2023
14. HARRIS E
    Depression After Head Injury Might Be Separate Disorder.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12543.
    PubMed    
    
    
    June 2023
15. JIN J
    Screening for Depression and Suicide Risk in Adults.
    JAMA. 2023;329:2102.
    PubMed    
    
    
    
16. O'CONNOR EA, Perdue LA, Coppola EL, Henninger ML, et al
    Depression and Suicide Risk Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;329:2068-2085.
    PubMed     Abstract available
    
    
    
17. BARRY MJ, Nicholson WK, Silverstein M, Chelmow D, et al
    Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2023;329:2057-2067.
    PubMed     Abstract available
    
    
    May 2023
18. HARRIS E
    Ketamine Noninferior to Electroconvulsive Therapy For Depression.
    JAMA. 2023 May 31. doi: 10.1001/jama.2023.9604.
    PubMed    
    
    
    March 2023
19. HARRIS E
    Combining Drugs Improved Hard-to-Treat Depression in Older Adults.
    JAMA. 2023 Mar 15. doi: 10.1001/jama.2023.3309.
    PubMed    
    
    
    February 2023
20. LEICHSENRING F, Heim N, Leweke F, Spitzer C, et al
    Borderline Personality Disorder: A Review.
    JAMA. 2023;329:670-679.
    PubMed     Abstract available
    
    
    November 2022
21. NELSON HD, Darney BG, Ahrens K, Burgess A, et al
    Associations of Unintended Pregnancy With Maternal and Infant Health Outcomes: A Systematic Review and Meta-analysis.
    JAMA. 2022;328:1714-1729.
    PubMed     Abstract available
    
    
    October 2022
22. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022 Oct 11. pii: 2797145. doi: 10.1001/jama.2022.16946.
    PubMed     Abstract available
    
    
    
23. JIN J
    Screening for Depression and Suicide Risk in Children and Adolescents.
    JAMA. 2022 Oct 11. pii: 2797147. doi: 10.1001/jama.2022.18187.
    PubMed    
    
    
    
24. BUKSTEIN OG
    Screening for Adolescent Depression and Suicide Risk.
    JAMA. 2022 Oct 11. pii: 2797148. doi: 10.1001/jama.2022.15223.
    PubMed    
    
    
    
25. VISWANATHAN M, Wallace IF, Cook Middleton J, Kennedy SM, et al
    Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022 Oct 11. pii: 2797146. doi: 10.1001/jama.2022.16310.
    PubMed     Abstract available
    
    
    August 2022
26. GOODWIN RD, Davidson L
    Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders.
    JAMA. 2022;328:585.
    PubMed    
    
    
    
27. HAN B, Tipperman D, Compton WM
    Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders-Reply.
    JAMA. 2022;328:585-586.
    PubMed    
    
    
    July 2022
28. IOSIFESCU DV
    Pharmacogenomic Testing for Next-Step Antidepressant Selection: Still a Work in Progress.
    JAMA. 2022;328:146-148.
    PubMed    
    
    
    
29. OSLIN DW, Lynch KG, Shih MC, Ingram EP, et al
    Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
    JAMA. 2022;328:151-161.
    PubMed     Abstract available
    
    
    June 2022
30. SLOMSKI A
    Even Low Amounts of Physical Activity Reduce Depression Risk.
    JAMA. 2022;327:2066.
    PubMed    
    
    
    May 2022
31. SLOMSKI A
    Antidepressant Combinations Compared With Monotherapy.
    JAMA. 2022;327:1641.
    PubMed    
    
    
    April 2022
32. HAN B, Volkow ND, Blanco C, Tipperman D, et al
    Trends in Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders, 2006-2019.
    JAMA. 2022;327:1566-1576.
    PubMed     Abstract available
    
    
    
33. CHEN MH, Liang CS, Su KP
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression.
    JAMA. 2022;327:1291-1292.
    PubMed    
    
    
    
34. LIANG CS, Tseng PT, Su KP
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression.
    JAMA. 2022;327:1290-1291.
    PubMed    
    
    
    
35. OKEREKE OI, Mischoulon D, Manson JE
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression-Reply.
    JAMA. 2022;327:1292.
    PubMed    
    
    
    January 2022
36. NIKNAM BA, Zubizarreta JR
    Using Cardinality Matching to Design Balanced and Representative Samples for Observational Studies.
    JAMA. 2022;327:173-174.
    PubMed    
    
    
    
37. HAHN EE, Munoz-Plaza CE, Pounds D, Lyons LJ, et al
    Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2022;327:41-49.
    PubMed     Abstract available
    
    
    December 2021
38. OKEREKE OI, Vyas CM, Mischoulon D, Chang G, et al
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    JAMA. 2021;326:2385-2394.
    PubMed     Abstract available
    
    
    November 2021
39. ABBASI J
    Closed Loop Device May Alleviate Treatment-Resistant Depression.
    JAMA. 2021;326:1785.
    PubMed    
    
    
    
40. CHEN MH, Tseng PT, Liang CS
    Depressive Symptom Assessment in Medically Ill Patients.
    JAMA. 2021;326:1748.
    PubMed    
    
    
    
41. HAHN SR
    Depressive Symptom Assessment in Medically Ill Patients.
    JAMA. 2021;326:1748-1749.
    PubMed    
    
    
    
42. BAUMGART P, Garrick T
    Depressive Symptom Assessment in Medically Ill Patients-Reply.
    JAMA. 2021;326:1749.
    PubMed    
    
    
    
43. CHRISTENSEN J, Trabjerg BB, Sun Y, Dreier JW, et al
    Association of Maternal Antidepressant Prescription During Pregnancy With Standardized Test Scores of Danish School-aged Children.
    JAMA. 2021;326:1725-1735.
    PubMed     Abstract available
    
    
    October 2021
44. SLOMSKI A
    Pediatric Depression and Anxiety Doubled During the Pandemic.
    JAMA. 2021;326:1246.
    PubMed    
    
    
    September 2021
45. SLOMSKI A
    Novel Oral Drug Rapidly Treats Postpartum Depression.
    JAMA. 2021;326:800.
    PubMed    
    
    
    August 2021
46. 
    A Simple Approach to Relieve Teens' Anxiety and Depression.
    JAMA. 2021;326:591.
    PubMed    
    
    
    June 2021
47. BAUMGART P, Garrick T
    Assessment of Depressive Symptoms in Medically Ill Patients.
    JAMA. 2021;325:2497-2498.
    PubMed    
    
    
    
48. LISS DT, Uchida T, Wilkes CL, Radakrishnan A, et al
    General Health Checks in Adult Primary Care: A Review.
    JAMA. 2021;325:2294-2306.
    PubMed     Abstract available
    
    
    May 2021
49. TOROUS J
    Digital Interventions for Adults With Symptoms of Depression and Children and Adolescents With Symptoms of Obsessive-Compulsive Disorder.
    JAMA. 2021;325:1839-1840.
    PubMed    
    
    
    
50. ASPVALL K, Andersson E, Melin K, Norlin L, et al
    Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.
    JAMA. 2021;325:1863-1873.
    PubMed     Abstract available
    
    
    
51. ARAYA R, Menezes PR, Claro HG, Brandt LR, et al
    Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.
    JAMA. 2021;325:1852-1862.
    PubMed     Abstract available
    
    
    April 2021
52. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    PubMed    
    
    
    
53. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    PubMed    
    
    
    
54. SLOMSKI A
    Low-Income African American Women With Hypertension and Depression.
    JAMA. 2021;325:1602.
    PubMed    
    
    
    March 2021
55. BAGLEY SM
    I Am Not Burned Out.
    JAMA. 2021;325:1155-1156.
    PubMed    
    
    
    
56. MORIN L, Savale L, Pham T, Colle R, et al
    Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777787. doi: 10.1001/jama.2021.3331.
    PubMed     Abstract available
    
    
    December 2020
57. RUBIN R
    Postpartum Depression Persists Longer Than Previously Thought.
    JAMA. 2020;324:2475.
    PubMed    
    
    
    
58. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    PubMed     Abstract available
    
    
    October 2020
59. BAUM A, Wisnivesky J, Basu S, Siu AL, et al
    Association of Geographic Differences in Prevalence of Uncontrolled Chronic Conditions With Changes in Individuals' Likelihood of Uncontrolled Chronic Conditions.
    JAMA. 2020;324:1429-1438.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge.